Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 32669 total
EPAC heads into its Q3 fiscal 2026 earnings print on July 8 with options traders positioned unusually bullishly — a sharp contrast to a week of broad industrial weakness. The most striking positioning signal is in the…
Short sellers moved aggressively this week across several names. Chewy leads the pack with SI hitting 72.4% of free float — up 3.3 points in just seven days. Bears show no sign of backing off the pet…
Short pressure is building across a range of names. Chewy now has short interest at 72.4% of free float — one of the most extreme readings in large-cap US markets. CoreWeave sits at 31.5% of FF, with availability still…
Bearish sentiment is rising in pockets of the market. CHWY tops the watch list with short interest at 72.4% of free float — one of the highest readings in the US market. Bears have piled in, according to ORTEX data.…
Today brings the first earnings of the week. LEVI reports Q2 2026 results after the close. PepsiCo drops its pre-recorded Q2 call tonight. Enerpac Tool Group and AZZ Inc. both report today as well. Tomorrow, Northern…
Analysts reshuffled their views across the payments and fintech space on July 8, with a wave of new recommendations and target price moves hitting several major names. MSCI led the upgrades. The index data giant saw…
Short sellers turned aggressive this week. Data as of July 6 shows notable increases across several names. Chewy leads the pack. SI hit 72.4% of free float — up 3.3 percentage points in seven days. That is one of the…
Infrastructure dealmaking grabbed attention today. MasTec agreed to buy Electrical Specialists for roughly $1.65 billion. The move extends MasTec's reach in electrical contracting. The deal signals continued appetite…
The week kicks off today with several confirmed earnings releases. LEVI reports Q2 2026 results after the close on Tuesday, July 8. The denim giant faces pressure from tariff-driven cost increases. PEP posts a…
Stifel analyst Adam Borg slashed his price target on CRWD from $790 to $220. That is a 72% cut. He kept a Buy rating, but the implied upside dropped sharply. CrowdStrike trades at a $203 billion market cap. Short…
Insider selling dominated filings over the past two weeks. The trend spans tech, retail, and aerospace. AST SpaceMobile CEO and founder Abel Avellan filed on June 23. He sold 2.5 million shares worth $146.7M at $58.68.…
SoundHound AI heads into the week with a familiar split — the stock just posted its best weekly gain in over a month, yet the short position barely budged and the borrow market remains completely frozen. The price move…
Arista Networks enters earnings season with the stock running hot, analysts broadly constructive, and its founder quietly reducing his stake — a tension worth watching as Q2 results approach on July 31. The price…
Palantir Technologies has broken sharply higher this week — up 14.6% to $132.54 — delivering a direct rebuke to the short book that spent the prior two weeks quietly building. The reversal is notable precisely because…
Short sellers are piling into vulnerable names. Chewy remains the most heavily shorted mid-cap in the US. Short interest sits at 72.4% of free float. Sable Offshore saw the week's biggest jump — SI surged 7.7…
Today brings the first action. EPAC — Enerpac Tool Group — reports Q3 2026 results this afternoon. Tomorrow, Tuesday, gets busy. LEVI reports Q2 results after the close. Denim demand and margin trends are in focus. PEP…
RBC Capital's Brian Abrahams published a wave of biotech calls on Monday. He raised his target on VRTX to $570 from $543, keeping a Buy rating. He also lifted BIIB to $242 from $227 on a Buy. The two upgrades came…
ABTC built a 10.5-million-share short position over several weeks. In a single session, 93% of it vanished. Why this matters: Three signals shifted simultaneously on July 6 — a near-total short cover, a put/call ratio…
Insider filings this month reveal a sharp split between bold buyers and heavy sellers across US markets. SMMT Chairman and CEO Robert Duggan filed a $50M purchase of Summit Therapeutics shares in June. He bought 3.8…
The last shares available to borrow on CLVT are nearly gone. Availability has crashed to 0.43% — down from 32% just four days ago and from over 113% on June 26. For every 230 shares already lent out, fewer than one…
